Hyperalgesia induced by low doses of thymulin injections: possible involvement of prostaglandin E2. 1997

B Safieh-Garabedian, and S A Kanaan, and R H Jalakhian, and S Poole, and S J Jabbur, and N E Saadé
Department of Biology, Faculty of Arts and Sciences, American University of Beirut, Lebanon. bared@aub.edu.lb

Thymulin injection into rats (20-150 ng) i.p. caused a significant reduction in both mechanical (paw pressure test) and thermal (hot plate and tail flick tests) nociceptive thresholds. Thymulin injection also doubled IL-1beta level in the liver of these animals. Induced hyperalgesia was reversed completely by alpha-MSH related tripeptide, Lys-D-Pro-Val in low doses, which is known to antagonize IL-1beta and PGE2 induced hyperalgesia, but was only partly reversed by IL-1beta related tripeptide, Lys-D-Pro-Thr at high doses, which is known to antagonize IL-1beta induced hyperalgesia only. We conclude from these results that thymulin causes hyperalgesia and that this effect is at least in part mediated via PGE2 and its effectiveness at low concentration implies a physiological role for this thymic hormone.

UI MeSH Term Description Entries
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009074 Melanocyte-Stimulating Hormones Peptides with the ability to stimulate pigmented cells MELANOCYTES in mammals and MELANOPHORES in lower vertebrates. By stimulating the synthesis and distribution of MELANIN in these pigmented cells, they increase coloration of skin and other tissue. MSHs, derived from pro-opiomelanocortin (POMC), are produced by MELANOTROPHS in the INTERMEDIATE LOBE OF PITUITARY; CORTICOTROPHS in the ANTERIOR LOBE OF PITUITARY, and the hypothalamic neurons in the ARCUATE NUCLEUS OF HYPOTHALAMUS. MSH,Melanocyte Stimulating Hormone,Melanocyte-Stimulating Hormone,Melanophore Stimulating Hormone,Melanotropin,MSH (Melanocyte-Stimulating Hormones),Melanophore-Stimulating Hormone,Hormone, Melanocyte Stimulating,Hormone, Melanocyte-Stimulating,Hormone, Melanophore Stimulating,Melanocyte Stimulating Hormones,Stimulating Hormone, Melanocyte,Stimulating Hormone, Melanophore
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011312 Pressure A type of stress exerted uniformly in all directions. Its measure is the force exerted per unit area. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Pressures
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005528 Foot The distal extremity of the leg in vertebrates, consisting of the tarsus (ANKLE); METATARSUS; phalanges; and the soft tissues surrounding these bones. Feet
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot

Related Publications

B Safieh-Garabedian, and S A Kanaan, and R H Jalakhian, and S Poole, and S J Jabbur, and N E Saadé
November 1994, Brain research,
B Safieh-Garabedian, and S A Kanaan, and R H Jalakhian, and S Poole, and S J Jabbur, and N E Saadé
September 1994, Neuroscience,
B Safieh-Garabedian, and S A Kanaan, and R H Jalakhian, and S Poole, and S J Jabbur, and N E Saadé
December 2016, Life sciences,
B Safieh-Garabedian, and S A Kanaan, and R H Jalakhian, and S Poole, and S J Jabbur, and N E Saadé
May 2007, The journal of pain,
B Safieh-Garabedian, and S A Kanaan, and R H Jalakhian, and S Poole, and S J Jabbur, and N E Saadé
August 2004, European journal of pharmacology,
B Safieh-Garabedian, and S A Kanaan, and R H Jalakhian, and S Poole, and S J Jabbur, and N E Saadé
July 2014, Neuropharmacology,
B Safieh-Garabedian, and S A Kanaan, and R H Jalakhian, and S Poole, and S J Jabbur, and N E Saadé
April 1995, Brain research,
B Safieh-Garabedian, and S A Kanaan, and R H Jalakhian, and S Poole, and S J Jabbur, and N E Saadé
April 1997, British journal of pharmacology,
B Safieh-Garabedian, and S A Kanaan, and R H Jalakhian, and S Poole, and S J Jabbur, and N E Saadé
April 1987, Japanese journal of pharmacology,
B Safieh-Garabedian, and S A Kanaan, and R H Jalakhian, and S Poole, and S J Jabbur, and N E Saadé
September 2003, The journal of pain,
Copied contents to your clipboard!